Also the systemic administration of IFN-β significantly inhibited glioma growth and reversed the microcirculation of the glioma tissues to that of the non-tumor brain tissue, suggesting the anti-proliferative effect is not due to only high local concentrations of the protein. The gene discussed is IFNB1; the disease is central nervous system cancer.